Article
Risks factors of liver fibrosis in a cohort of intravenous drug users coinfected with HIV and HCV in the HAART era: the role of mixed steatosis.
Gastroenterologie clinique et biologique - 1 Oct 2007
Lanternier Fanny, Roulot Dominique, Bentata Michele, Pol Stanislas, Viard Jean-Paul, Gordien Emmanuel, Jeantils Vincent, Ziol Marianne, Lortholary Olivier
Abstract excerpt
Factors associated with the occurrence of severe liver fibrosis in HIV/HCV (hepatitis C virus) coinfected patients remain poorly understood. We thus questioned which factors influenced the occurrence of fibrosis in a cohort of HIV/HCV coinfected intravenous drug user patients. HIV/HCV coinfected intravenous drug user patients naive of anti-HCV therapy for whom a liver biopsy was performed between 1996 and 2003...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.